Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Clinical trials sponsored by Shenzhen Hepalink Pharmaceutical Group Co., Ltd., explained in plain language.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 002399 SZSE

A Chinese pharmaceutical company specializing in heparin and other active pharmaceutical ingredients.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New cancer drug H1710 enters first human tests

Disease control Recruiting now

This early-phase trial is testing a new drug called H1710 in 36 adults with advanced solid tumors who have no standard treatment options left. The main goal is to check the drug's safety, find the right dose, and see how the body processes it. Researchers will also watch for any …

Phase: PHASE1 • Sponsor: Shenzhen Hepalink Pharmaceutical Group Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC